Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.250
+0.110 (3.50%)
At close: Dec 24, 2024, 4:00 PM
3.200
-0.050 (-1.54%)
After-hours: Dec 24, 2024, 4:38 PM EST
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for CATX stock have an average target of 17.25, with a low estimate of 6.00 and a high estimate of 22. The average target predicts an increase of 430.77% from the current stock price of 3.25.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 25, 2024.
Analyst Ratings
The average analyst rating for CATX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 4 | 4 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $25 → $16 | Buy | Maintains | $25 → $16 | +392.31% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $24 → $6 | Strong Buy → Hold | Downgrades | $24 → $6 | +84.62% | Nov 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +392.31% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +515.38% | Oct 24, 2024 |
| UBS | UBS | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +515.38% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
1.21M
from 1.43M
Decreased by -15.83%
Revenue Next Year
693.15K
from 1.21M
Decreased by -42.57%
EPS This Year
-0.86
from -1.74
EPS Next Year
-1.11
from -0.86
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.1M | 2.5M | 2.5M | |||
| Avg | 1.2M | 693,151 | 688,500 | |||
| Low | 833,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 45.0% | 107.0% | 263.6% | |||
| Avg | -15.8% | -42.6% | -0.7% | |||
| Low | -41.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.81 | -0.75 | -0.72 | |
| Avg | -0.86 | -1.11 | -1.21 | |
| Low | -0.93 | -1.75 | -1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.